Article

Silicone hydrogel lens sales soared during 2005

Atlanta?Silicone hydrogel contact lens sales are speeding up so rapidly that they may overtake traditional soft contact lens sales by the end of 2007, according to estimates based on retail audit data by the A.C. Nielsen Co. CIBA Vision holds the leading share of the silicone hydrogel segment at 49.5% of retail sales year-to-date, August 2005, according to the data.

Atlanta-Silicone hydrogel contact lens sales are speeding up so rapidly that they may overtake traditional soft contact lens sales by the end of 2007, according to estimates based on retail audit data by the A.C. Nielsen Co. CIBA Vision holds the leading share of the silicone hydrogel segment at 49.5% of retail sales year-to-date, August 2005, according to the data.

"As more silicone hydrogel lenses are introduced, we are witnessing an acceleration of eye-care professionals converting to these advanced materials," said Karen Gough, president, CIBA Vision's Americas Region.

"If present trends continue, silicone hydrogels will become the dominant lens material in the United States during 2007, ahead of our prior forecasts," she continued.

Since September 2004, when CIBA Vision introduced its 2-week silicone hydrogel lens, O2OPTIX, the silicone hydrogel segment's share of retail sales has grown on an average of 1.2 points per month. By year-end 2006, the segment's share is likely to exceed 45%.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.